Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus 16”

264 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 264 results

Not applicableUnknownNCT01427777
What this trial is testing

3-year Immunogenicity Evaluation of Quadrivalent HPV Vaccine in China

Who this might be right for
Anogenital Human Papilloma Virus Infection
Guangxi Center for Disease Control and Prevention 300
Large-scale testing (Phase 3)Active Not RecruitingNCT04534205
What this trial is testing

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

Who this might be right for
Unresectable Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck CancerRecurrent Head and Neck Cancer
BioNTech SE 358
Large-scale testing (Phase 3)Study completedNCT00518180
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents

Who this might be right for
Meningococcal MeningitisHuman Papillomavirus InfectionPertussis+1 more
Novartis Vaccines 1,620
Large-scale testing (Phase 3)Looking for participantsNCT05027776
What this trial is testing

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 1,348
Early research (Phase 1)Looking for participantsNCT07047989
What this trial is testing

NWRD09 for HPV-16 Related Cervical HSIL

Who this might be right for
High-grade Squamous Intraepithelial Lesion (HSIL)
Newish Biotech (Wuxi) Co., Ltd. 9
Large-scale testing (Phase 3)Study completedNCT01190176
What this trial is testing

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 34
Large-scale testing (Phase 3)Ended earlyNCT05584332
What this trial is testing

A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerGenital WartCIN1+9 more
Shanghai Bovax Biotechnology Co., Ltd. 3,131
Testing effectiveness (Phase 2)Study completedNCT05694728
What this trial is testing

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papilloma Virus Infection
Beijing Health Guard Biotechnology, Inc 780
Large-scale testing (Phase 3)Study completedNCT00316706
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Who this might be right for
Cervical Intraepithelial NeoplasiaPapillomavirus Infection
GlaxoSmithKline 1,245
Not applicableActive Not RecruitingNCT06120205
What this trial is testing

SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening

Who this might be right for
HpvHPV 16 InfectionHPV Infection+1 more
Teal Health, Inc. 870
Testing effectiveness (Phase 2)Study completedNCT02724254
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

Who this might be right for
Condyloma
Vaxart 218
Testing effectiveness (Phase 2)Study completedNCT02280811
What this trial is testing

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

Who this might be right for
Vaginal CancerCervical CancerAnal Cancer+2 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Ended earlyNCT05357027
What this trial is testing

HPV16 E6 TCR T Cells for Cervical Carcinoma

Who this might be right for
Cervical Carcinoma
TCRCure Biopharma Ltd. 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07809997
What this trial is testing

Phase I/II Trial of Electroporation-Delivered pBI-4 Vaccine (TriGrid™ PVX4) for Treatment of Women With HPV16-Positive CIN1 or Persistent Infection

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 1Human Papillomavirus 16 Infection
Chang Gung Memorial Hospital 94
Testing effectiveness (Phase 2)WithdrawnNCT06099418
What this trial is testing

Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.

Who this might be right for
HPV-Related Cervical CarcinomaHPV-Related MalignancyCervical Cancer
Nykode Therapeutics ASA
Large-scale testing (Phase 3)WithdrawnNCT02100618
What this trial is testing

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Early research (Phase 1)Ended earlyNCT03815682
What this trial is testing

RPTR-147 in Patients With Selected Solid Tumors and Lymphomas

Who this might be right for
Solid TumorLymphoma
Repertoire Immune Medicines 23
Large-scale testing (Phase 3)UnknownNCT06207175
What this trial is testing

Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 1,260
Testing effectiveness (Phase 2)Study completedNCT02128126
What this trial is testing

Study of the Therapeutic Vaccine (ISA101/ISA101b) to Treat Advanced or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
ISA Pharmaceuticals 93
Testing effectiveness (Phase 2)Study completedNCT04369937
What this trial is testing

HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma

Who this might be right for
HPV-Related Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma
Dan Zandberg 18
Next Page